Michael Sokolov

ETH Zurich, Swiss Data Science Center

Papers

3

Total Citations

48

H-Index

2

About

Michael Sokolov is a leading figure in the digital transformation of bioprocess development, specializing in high-throughput automation, online monitoring, and machine learning for biomanufacturing. His work centers on accelerating the transition from strain screening to robust production processes, particularly for therapeutic proteins like monoclonal antibodies. Sokolov’s major contributions include pioneering the use of mini-bioreactor platforms for multivariate prediction, as demonstrated in his highly cited 2018 work on endopolygalacturonase production with *Saccharomyces cerevisiae* (28 citations). He further advanced the field by integrating online multivariate analysis with robotic cultivation systems (2020, 18 citations), enabling real-time, data-rich decision-making during microbial screening. Most notably, his 2024 paper on self-driving development of perfusion processes (2 citations) represents a cutting-edge leap toward autonomous bioprocessing, where AI agents orchestrate experiments to optimize yields with minimal human intervention. With a growing citation impact, Sokolov’s work is instrumental in reducing the time and cost of biopharmaceutical innovation, making him a key contributor to the next generation of smart, automated biomanufacturing.

Research Focus

Key Achievements

2
H-Index
3
Papers
48
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Accelerated Bioprocess Development of Endopolygalacturonase-Production with Saccharomyces cerevisiae Using Multivariate Prediction in a 48 Mini-Bioreactor Automated Platform
28 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: ETH Zurich, Swiss Data Science Center

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago